Dipraglurant Uses, Dosage, Side Effects and more
Dipraglurant has been used in trials studying the treatment of Parkinson's Disease. It is a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM).
| Attribute | Details |
|---|---|
| Trade Name | Dipraglurant |
| Generic | Dipraglurant |
| Dipraglurant Other Names | Dipraglurant |
| Type | |
| Formula | C16H12FN3 |
| Weight | Average: 265.291 Monoisotopic: 265.101525561 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
